7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2010-12-31 
      
    		                         
      cash flow from operating activities
    		                         
      net income
    		842,000,000 468,000,000 945,000,000 -120,000,000 1,140,000,000 1,170,000,000 888,000,000 1,198,000,000 1,375,000,000 860,000,000 1,263,000,000 1,927,000,000 2,746,000,000 3,755,000,000 4,876,000,000 1,537,000,000 828,000,000 103,000,000 -146,000,000 -1,112,000,000 -3,575,000,000 -8,131,000,000 -2,013,000,000 -1,036,000,000 1,226,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                         
      discontinued operations
    		   0 0 0 -182,000,000         24,000,000 2,000,000 -3,000,000 445,000,000 -37,000,000 -80,000,000   0 21,000,000 
      depreciation, depletion and amortization of assets
    		2,061,000,000 1,936,000,000 1,917,000,000 1,977,000,000 1,926,000,000 1,775,000,000 1,693,000,000 1,723,000,000 1,712,000,000 1,709,000,000 1,721,000,000 1,819,000,000 1,736,000,000 1,728,000,000 1,643,000,000 1,966,000,000 1,916,000,000 2,371,000,000 2,194,000,000 1,754,000,000 1,915,000,000 2,186,000,000 2,242,000,000 2,271,000,000 545,000,000 
      deferred income tax provision
    		   -279,000,000 -47,000,000 -44,000,000 -91,000,000 -91,000,000 50,000,000 81,000,000 17,000,000              170,000,000 
      asset impairments and related items
    		                         
      (gains) losses on sales of assets and other
    		                         
      other noncash charges to income
    		183,000,000 235,000,000 267,000,000                 285,000,000    362,000,000 461,000,000 
      changes in operating assets and liabilities:
    		                         
      increase in trade receivables
    		297,000,000 140,000,000 -85,000,000                       
      increase in inventories
    		-227,000,000 292,000,000 -49,000,000 180,000,000 561,000,000 -677,000,000 -110,000,000 -47,000,000 31,000,000 173,000,000 -248,000,000 -134,000,000           -70,000,000   
      increase in other current assets
    		  -52,000,000  73,000,000 140,000,000 6,000,000 354,000,000 -20,000,000 -225,000,000 -122,000,000 -22,000,000 -325,000,000 170,000,000 -158,000,000 53,000,000 -67,000,000 -23,000,000 -82,000,000       
      decrease in accounts payable and accrued liabilities
    		  -686,000,000 -231,000,000   -454,000,000    -1,174,000,000    -187,000,000        -4,401,000,000   
      increase in current domestic and foreign income taxes
    		69,000,000 -258,000,000 20,000,000 47,000,000 305,000,000 12,000,000 195,000,000 -86,000,000 178,000,000 -118,000,000 251,000,000 -80,000,000 -432,000,000 122,000,000 205,000,000    25,000,000   17,000,000 48,000,000   
      operating cash flow from continuing operations
    		   3,556,000,000        3,975,000,000 4,267,000,000 5,329,000,000 3,239,000,000 3,231,000,000 2,910,000,000 3,324,000,000 788,000,000 1,367,000,000 815,000,000 436,000,000 1,224,000,000  2,459,000,000 
      operating cash flow from discontinued operations, net of taxes
    		               -139,000,000 208,000,000 -10,000,000 122,000,000 37,000,000 37,000,000 -76,000,000 115,000,000   
      net cash from operating activities
    		2,790,000,000 2,960,000,000 2,148,000,000 3,356,000,000 3,682,000,000 2,394,000,000 2,007,000,000 3,239,000,000 3,129,000,000 3,070,000,000 2,870,000,000 3,975,000,000 4,267,000,000 5,329,000,000 3,239,000,000 3,092,000,000 3,118,000,000 3,314,000,000 910,000,000 1,404,000,000 852,000,000 360,000,000 1,339,000,000 2,009,000,000 2,742,000,000 
      cash flow from investing activities
    		                         
      capital expenditures
    		-1,768,000,000 -1,998,000,000 -1,908,000,000 -1,781,000,000 -1,683,000,000 -1,771,000,000 -1,783,000,000 -1,544,000,000 -1,619,000,000 -1,646,000,000 -1,461,000,000 -1,520,000,000 -1,147,000,000 -972,000,000 -858,000,000 -937,000,000 -656,000,000 -698,000,000 -579,000,000 -614,000,000 -246,000,000 -382,000,000 -1,293,000,000   
      free cash flows
    		1,022,000,000 962,000,000 240,000,000 1,575,000,000 1,999,000,000 623,000,000 224,000,000 1,695,000,000 1,510,000,000 1,424,000,000 1,409,000,000 2,455,000,000 3,120,000,000 4,357,000,000 2,381,000,000 2,155,000,000 2,462,000,000 2,616,000,000 331,000,000 790,000,000 606,000,000 -22,000,000 46,000,000   
      change in capital accrual
    		-80,000,000 -12,000,000 5,000,000 135,000,000 -15,000,000 -75,000,000 51,000,000 73,000,000 -53,000,000 25,000,000 -20,000,000 145,000,000 70,000,000 -29,000,000 -39,000,000 180,000,000 11,000,000 -19,000,000 -75,000,000 206,000,000 17,000,000 -307,000,000 -435,000,000   
      purchases of assets, businesses and equity investments
    		-123,000,000 -56,000,000 -52,000,000 -92,000,000                      
      proceeds from sales of assets
    		780,000,000      98,000,000  325,000,000 26,000,000 54,000,000  238,000,000 57,000,000 267,000,000           
      equity investments and other
    		-68,000,000 -77,000,000 -82,000,000 -63,000,000 -85,000,000 -30,000,000 -34,000,000 -48,000,000 -47,000,000 -355,000,000 -20,000,000 -21,000,000 -23,000,000 -69,000,000 -3,000,000 427,000,000 6,000,000 -17,000,000 -10,000,000 -79,000,000 -15,000,000 61,000,000 142,000,000  65,000,000 
      net cash used by investing activities
    		-1,259,000,000 -1,999,000,000 -731,000,000 -1,790,000,000 -9,119,000,000 -1,871,000,000 -1,810,000,000 -1,969,000,000 -1,474,000,000 -1,939,000,000 -1,598,000,000 -1,898,000,000 -1,019,000,000 -1,293,000,000 -662,000,000 -51,000,000 -166,000,000 -754,000,000 -282,000,000 1,579,000,000 -292,000,000 -576,000,000 -1,530,000,000   
      cash flow from financing activities
    		                         
      proceeds from long-term debt
    		   0                      
      payments of long-term debt
    		-1,304,000,000 -1,762,000,000 -518,000,000 -507,000,000    0 0 0 -22,000,000 -1,159,000,000 -1,217,000,000 -3,849,000,000 -3,259,000,000  -4,381,000,000 0 -174,000,000       
      proceeds from issuance of common stock
    		17,000,000 906,000,000 25,000,000 13,000,000 67,000,000 416,000,000 88,000,000 43,000,000 55,000,000 7,000,000 30,000,000 2,000,000 174,000,000 90,000,000 27,000,000  13,000,000 5,000,000 6,000,000   18,000,000 90,000,000  3,000,000 
      purchases of treasury stock
    		   -18,000,000 0   -187,000,000 -434,000,000 -445,000,000 -732,000,000 -632,000,000 -1,899,000,000 -532,000,000 -36,000,000    -3,000,000 -8,000,000 0     
      cash dividends paid on common and preferred stock
    		-408,000,000 -398,000,000 -380,000,000 -377,000,000 -371,000,000 -366,000,000 -332,000,000 -330,000,000 -347,000,000 -368,000,000 -320,000,000 -321,000,000 -324,000,000 -323,000,000 -216,000,000 -209,000,000 -210,000,000 -209,000,000 -211,000,000 -211,000,000      
      contributions from noncontrolling interest
    		39,000,000 51,000,000 63,000,000 54,000,000                      
      payment for taxes related to stock-based award settlement
    		                         
      other financing
    		24,000,000 -40,000,000 -122,000,000 -152,000,000 90,000,000 -44,000,000 -141,000,000 -35,000,000 -134,000,000 -28,000,000 -36,000,000 -48,000,000 -25,000,000 -33,000,000 -24,000,000 -32,000,000 -18,000,000 -15,000,000 -15,000,000 -320,000,000 -39,000,000 136,000,000 -196,000,000 264,000,000  
      net cash provided (used) by financing activities
    		   -1,202,000,000                      
      increase in cash, cash equivalents, restricted cash and restricted cash equivalents
    		-164,000,000 -282,000,000 485,000,000 364,000,000 -102,000,000 562,000,000 -131,000,000    192,000,000 -253,000,000 -122,000,000 -550,000,000 -852,000,000 509,000,000 -2,472,000,000 2,298,000,000 274,000,000 120,000,000    -1,791,000,000  
      cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of period
    		0 0 2,157,000,000  0 0 1,464,000,000  0 0 1,026,000,000  0 0 2,803,000,000  0 0 2,194,000,000  0 0 3,574,000,000   
      cash, cash equivalents, restricted cash and restricted cash equivalents — end of period
    		-164,000,000 -282,000,000 2,642,000,000  -102,000,000 562,000,000 1,333,000,000  116,000,000 -685,000,000 1,218,000,000  -122,000,000 -550,000,000 1,951,000,000  -2,472,000,000 2,298,000,000 2,468,000,000  861,000,000 -1,151,000,000 2,364,000,000   
      the accompanying notes are an integral part of these consolidated condensed financial statements.
    		                         
      millions
    		0 0 2,025,000,000  0 0 2,024,000,000                   
      deferred income tax benefit
    		 -17,000,000 -129,000,000          272,000,000 203,000,000 -2,240,000,000  20,000,000 -131,000,000 -81,000,000 -400,000,000 -374,000,000 -1,525,000,000 -218,000,000   
      gain on sales of assets and other
    		                         
      decrease in other current assets
    		                         
      increase in accounts payable and accrued liabilities
    		           337,000,000 -1,586,000,000   272,000,000 118,000,000         
      net cash used by financing activities
    		 -1,243,000,000 -932,000,000   39,000,000 -328,000,000 -455,000,000 -1,539,000,000 -1,816,000,000 -1,080,000,000 -2,330,000,000 -3,370,000,000 -4,586,000,000 -3,429,000,000  -5,424,000,000 -262,000,000 -354,000,000   -935,000,000 -1,019,000,000   
      proceeds from sales of assets and equity investments
    		  1,306,000,000                       
      other noncash charges (benefit) to income
    		                         
      losses (gains) on sales of assets and other
    		                         
      undistributed losses (earnings) from equity investments
    		                         
      dry hole expense
    		                         
      increase in joint interest receivables and other current assets
    		                         
      operating cash flow from discontinued operations
    		                         
      proceeds from sale of assets and equity investments
    		                      112,000,000 1,334,000,000  
      draws on receivables securitization facility
    		       0    0 0             
      payment of receivables securitization facility
    		       0    0 0             
      redemption of preferred stock
    		       0 -679,000,000                 
      financing portion of net cash paid for derivative instruments
    		                    -10,000,000     
      deferred payments for purchases of assets and businesses
    		                         
      cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of year
    		                         
      cash, cash equivalents, restricted cash and restricted cash equivalents — end of year
    		                         
      oxy 2024 form 10-k
    		                         
      asset impairments and other charges
    		        0       131,000,000 17,000,000 21,000,000 135,000,000       
      (gains) losses on sales of assets
    		                         
      noncash charges to income and other
    		      138,000,000   -207,000,000 156,000,000               
      increase in receivables
    		    170,000,000 -626,000,000 -76,000,000     -235,000,000 2,293,000,000 -917,000,000 -1,238,000,000 -720,000,000 -187,000,000 -242,000,000 -937,000,000    3,909,000,000   
      gains on sales of assets
    		        -192,000,000 -1,000,000 -4,000,000               
      noncash charges (benefits) to income and other
    		                         
      purchases of assets and equity investments
    		                         
      proceeds from sales of businesses and assets
    		                         
      contribution from noncontrolling interest
    		     42,000,000 57,000,000                   
      purchases of businesses and assets
    		      -142,000,000  -80,000,000 11,000,000 -151,000,000  -157,000,000 -280,000,000 -29,000,000  -9,000,000 -8,000,000 -105,000,000       
      purchase of businesses, assets and equity investments
    		                         
      investing cash flow from continuing operations
    		           -1,898,000,000 -1,019,000,000 -1,293,000,000 -662,000,000 -20,000,000 -146,000,000 -735,000,000 -273,000,000 1,589,000,000 -286,000,000 -572,000,000 -1,509,000,000   
      investing cash flow from discontinued operations
    		               -31,000,000 -20,000,000 -19,000,000 -9,000,000       
      debt issuance costs
    		                         
      financing cash flow from continuing operations
    		           -2,330,000,000 -3,370,000,000 -4,586,000,000 -3,429,000,000 -2,531,000,000 -5,422,000,000 -259,000,000 -352,000,000 -2,861,000,000 303,000,000     
      financing cash flow from discontinued operations
    		               -1,000,000 -2,000,000 -3,000,000 -2,000,000       
      oxy 2023 form 10-k
    		                         
      noncash charges (benefit) to income and other
    		                         
      decrease in receivables
    		                         
      financing portion of net cash received for derivative instruments
    		             61,000,000 79,000,000           
      decrease in cash, cash equivalents, restricted cash and restricted cash equivalents
    		        116,000,000             -1,151,000,000 -1,210,000,000   
      decrease (increase) in receivables
    		          1,010,000,000               
      (gain) loss on sales of equity investments and other assets
    		                         
      undistributed earnings from affiliates
    		                         
      payment of liabilities associated with the sale of future royalties
    		                         
      gain on sales of assets
    		            -74,000,000 -23,000,000 -135,000,000           
      other noncash reconciling items
    		            20,000,000 -515,000,000 34,000,000  189,000,000         
      financing portion of net cash received (paid) for derivative instruments
    		                 -43,000,000 45,000,000       
      decrease in inventories
    		                         
      decrease (increase) in inventories
    		              439,000,000           
      purchase of businesses and assets
    		                   -12,000,000 -54,000,000 -13,000,000 -35,000,000   
      proceeds from long-term debt, net - occidental
    		                         
      payments of long-term debt, net - occidental
    		                         
      proceeds from long-term debt, net - wes
    		                         
      proceeds from issuance of common and preferred stock
    		                   8,000,000    18,000,000  
      distributions to noncontrolling interest
    		                         
      oxy 2021 form 10-k
    		                         
      (gains) losses on sales of equity investments and other assets
    		                         
      increase in inventory
    		                         
      increase in current domestic and international income taxes
    		                45,000,000         
      proceeds from sales of other assets and equity investments
    		                         
      proceeds from long-term debt, net of issuance costs
    		                         
      gains on sales of equity investments and other assets
    		                 -3,000,000 -111,000,000       
      decrease in inventory
    		                         
      proceeds from sales of equity investments and other assets
    		                 7,000,000 496,000,000       
      other noncash benefits to income
    		                  -301,000,000       
      (increase) in inventory
    		                  -311,000,000       
      (decrease) in accounts payable and accrued liabilities
    		                  -42,000,000       
      other operating
    		                         
      asset impairments and other items
    		                    2,695,000,000 6,452,000,000 1,768,000,000   
      losses (gains) on sales of assets
    		                         
      changes in operating assets and liabilities
    		                         
      proceeds from sale of assets
    		                    12,000,000     
      investing cash flow from discontinued operations, net of taxes
    		                    -6,000,000 -4,000,000 -21,000,000   
      proceeds from short-term borrowings and revolvers - wes
    		                         
      payment of revolvers - wes
    		                         
      distributions paid to noncontrolling interest
    		                         
      financing cash flow from discontinued operations, net of taxes
    		                    -2,000,000     
      net cash (used) provided by financing activities
    		                         
      supplemental non-cash activities:
    		                         
      non-cash investing activities
    		                         
      exchange equity investment in wes
    		                         
      non-cash financing activities
    		                         
      settlement of long-term debt - wes
    		                         
      other noncash (gains) charges to income
    		                     467,000,000 -550,000,000   
      decrease (increase) in other current assets
    		                     -132,000,000 324,000,000   
      preferred stock issuance costs
    		                         
      cash dividends paid
    		                     -714,000,000 -913,000,000   
      gain on sales of equity investments and other assets
    		                      -7,000,000   
      undistributed losses (income) from affiliates
    		                      174,000,000   
      dry hole expenses
    		                      18,000,000   
      payments of long-term debt, net - wes
    		                         
      cash and cash equivalents — beginning of year
    		                         
      gain on sale of assets
    		                         
      cash from operating activities - continuing operations
    		                         
      cash used by operating activities - discontinued operations
    		                         
      cash used by investing activities - continuing operations
    		                         
      cash used by investing activities - discontinued operations
    		                         
      proceeds from wes revolvers
    		                         
      cash dividends paid to common stockholders
    		                         
      cash provided (used) by financing activities - continuing operations
    		                         
      cash used by financing activities - discontinued operations
    		                         
      net cash from (used) by financing activities
    		                         
      cash and cash equivalents — beginning of period
    		                         
      undistributed earnings from equity investments
    		                         
      payments for purchases of assets and businesses
    		                         
      sales of assets
    		                         
      purchase of treasury stock
    		                         
      decrease in cash and cash equivalents
    		                         
      cash and cash equivalents — end of period
    		                         
      adjustments to reconcile net income to net cash provided byoperating activities:
    		                         
      other noncash charges (benefits) to income
    		                         
      income from discontinued operations
    		                         
      sales of equity investments and assets
    		                         
      other
    		                         
      increase in cash, cash equivalents, and restricted cash
    		                         
      cash, cash equivalents, and restricted cash — beginning of year
    		                         
      cash and cash equivalents — end of year
    		                         
      increase in cash and cash equivalents
    		                        475,000,000 
      net distributions from equity investments
    		                         
      other investing
    		                         
      gain on sale of equity investments and other assets
    		                         
      change in restricted cash
    		                         
      payment of long-term debt
    		                         
      adjustments to reconcile income to net cash provided byoperating activities:
    		                         
      the accompanying notes are an integral part of these consolidated financial statements.
    		                         
      special cash distributions from california resources
    		                         
      asset impairments
    		                         
      (gain) loss on sale of assets
    		                         
      sale of assets
    		                         
      net cash from financing activities
    		                         
      purchases of assets
    		                         
      purchase of businesses and other assets
    		                         
      proceeds from short-term borrowings
    		                         
      net cash provided (used by) financing activities
    		                         
      loss on sale of assets
    		                         
      cash and cash equivalents—beginning of period
    		                         
      cash and cash equivalents—end of period
    		                         
      gain on sale of equity investments
    		                         
      gain on sale of assets and equity investments
    		                         
      sale of assets and equity investments
    		                         
      purchases of long-term debt
    		                         
      contributions from (distributions to) noncontrolling interest
    		                         
      gain on sale of equity investment
    		                         
      sale of equity investment
    		                         
      gains on disposition of assets
    		                         
      dry hole and impairment expense
    		                        15,000,000 
      adjustments to reconcile net income to net cash from operating activities
    		                         
      decrease (increase) in prepaid expenses and other assets
    		                         
      (gains) losses on disposition of assets
    		                         
      excess share-based tax benefits and other
    		                        17,000,000 
      income from equity investments
    		                         
      sales of equity investments and available-for-sale investments
    		                         
      adjustments to reconcile net income to net cash provided by
    		                         
      operating activities:
    		                         
      losses (gains) on disposition of assets
    		                         
      excess share-based tax benefits
    		                         
      purchases of short-term investments
    		                         
      sales of short-term investments
    		                         
      depreciation, depletion and amortization expense
    		                         
      other non-cash charges to income
    		                         
      sales of investments
    		                         
      equity investments and other investing
    		                         
      excess tax benefits related to share-based payments
    		                         
      stock options exercised
    		                         
      decrease (increase) in accounts and notes receivable
    		                         
      decrease in current domestic and foreign income taxes
    		                         
      payments of long-term debt and capital lease liabilities
    		                         
      gain on disposition of assets
    		                         
      sale of businesses and disposal of property, plant, and equipment
    		                         
      short term investments - purchases
    		                         
      short term investments - sales
    		                         
      sale of equity investments and available-for-sale investments
    		                         
      payments of long-term debt and notes payable
    		                         
      the accompanying notes are an integral part of these financial statements.
    		                         
      adjustments to reconcile net income to net cash from operating
    		                         
      activities:
    		                         
      sales of businesses and disposal of property, plant, and equipment
    		                         
      cumulative effect of changes in accounting principles
    		                         
      reversal of tax reserves
    		                         
      gain on lyondell stock issuance
    		                         
      increase in accounts and notes receivable
    		                         
      increase in prepaid expenses and other assets
    		                         
      sale of businesses and disposal of property, plant and equipment
    		                         
      purchase of businesses
    		                         
      purchase of short-term investments
    		                         
      sale of short-term investments
    		                         
      repurchase of trust preferred securities
    		                         
      adjustments to reconcile income to net cash from operating activities:
    		                         
      payments on long-term debt and capital lease liabilities
    		                         
      income from continuing operations
    		                         
      purchase of businesses and other interests
    		                         
      sales of businesses and disposal of property, plant and equipment
    		                         
      redemption of trust preferred securities
    		                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.